Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D. Vonk MC, et al. Among authors: zohar s. Ann Rheum Dis. 2008 Jan;67(1):98-104. doi: 10.1136/ard.2007.071464. Epub 2007 May 25. Ann Rheum Dis. 2008. PMID: 17526554 Clinical Trial.
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E; Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group. Farge D, et al. Among authors: zohar s. Br J Haematol. 2002 Dec;119(3):726-39. doi: 10.1046/j.1365-2141.2002.03895.x. Br J Haematol. 2002. PMID: 12437652 Free article. Clinical Trial.
A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B. Lefrère F, et al. Among authors: zohar s. Haematologica. 2006 Apr;91(4):550-3. Haematologica. 2006. PMID: 16585020 Clinical Trial.
Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?
Merlin E, Zohar S, Jérôme C, Veyrat-Masson R, Marceau G, Paillard C, Auvrignon A, Le Moine P, Gandemer V, Sapin V, Halle P, Boiret-Dupré N, Chevret S, Deméocq F, Dubray C, Kanold J. Merlin E, et al. Among authors: zohar s. Bone Marrow Transplant. 2009 Jun;43(12):919-25. doi: 10.1038/bmt.2008.412. Epub 2008 Dec 22. Bone Marrow Transplant. 2009. PMID: 19104490 Clinical Trial.
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
Lefrère F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. Lefrère F, et al. Among authors: zohar s. Bone Marrow Transplant. 2006 Apr;37(8):725-9. doi: 10.1038/sj.bmt.1705308. Bone Marrow Transplant. 2006. PMID: 16518433
Esophageal replacement by allogenic aorta in a porcine model.
Gaujoux S, Le Balleur Y, Bruneval P, Larghero J, Lecourt S, Domet T, Lambert B, Zohar S, Prat F, Cattan P. Gaujoux S, et al. Among authors: zohar s. Surgery. 2010 Jul;148(1):39-47. doi: 10.1016/j.surg.2009.12.002. Epub 2010 Feb 1. Surgery. 2010. PMID: 20117812
149 results